DPX-RSV: Phase I start

This half, Immunovaccine will begin an observer-blind,

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE